VistaGen Therapeutics
VTGN
#10985
Rank
ยฃ6.28 M
Marketcap
ยฃ0.14
Share price
2.57%
Change (1 day)
-95.38%
Change (1 year)

VistaGen Therapeutics (VTGN) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : ยฃ8.48 Million

According to VistaGen Therapeutics 's latest financial reports the company's total liabilities are ยฃ8.48 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

VistaGen Therapeutics - Total liabilities on balance sheet (from 2008 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31ยฃ7.29 M-3.38%
2022-03-31ยฃ7.55 M-36.14%
2021-03-31ยฃ11.82 M27.58%
2020-03-31ยฃ9.26 M74.02%
2019-03-31ยฃ5.32 M71.43%
2018-03-31ยฃ3.1 M25.85%
2017-03-31ยฃ2.46 M-10.59%
2016-03-31ยฃ2.76 M-80.33%
2015-03-31ยฃ14.03 M79.05%
2014-03-31ยฃ7.83 M-11.36%
2013-03-31ยฃ8.84 M133.91%
2012-03-31ยฃ3.78 M
2010-12-31ยฃ0 M123.63%
2009-12-31ยฃ0 M-49.42%
2008-12-31ยฃ0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
ยฃ17.66 M 108.17%๐Ÿ‡บ๐Ÿ‡ธ USA